Featured Topics
Calendar

April 24, 2026

May 12, 2026

Q1 2026 Results / Quarterly Statement
Q1 2026 Media Update
Press Releases
Share Price / Index
April 16, 2026
Not intended for U.S. and UK Media
Asundexian OCEANIC-STROKE Phase III study results demonstrating substantial reduction in ischemic stroke with no increase in ISTH major bleeding versus placebo published in New England Journal of Medicine
March 23, 2026
First approval for Bayer’s low-dose MRI contrast agent in Japan
March 16, 2026
Not intended for U.S. and UK Media
Finerenone meets primary endpoint in pivotal Phase III FIND-CKD study in patients with non-diabetic chronic kidney disease

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.